<DOC>
	<DOCNO>NCT02508337</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety XG-102 ( 900Âµg ) compare vehicle treatment subject inflammation pain follow cataract surgery .</brief_summary>
	<brief_title>Efficacy Safety XG-102 Reduction Post-cataract Surgery Intraocular Inflammation Pain</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Have provide write informed consent , approve appropriate institutional review board ; Be great equal 18 year age either sex race ; Be plan undergo unilateral cataract extraction via phacoemulsification posterior chamber intraocular lens ( PCIOL ) implantation study eye ; Have pinhole visual acuity ( VA ) &lt; 1.0 logarithm minimum angle resolution ( logMAR ) operative eye fellow eye measure use Early Treatment Diabetic Retinopathy Study ( ETDRS ) chart Visit 1 ; ( For female childbearing potential ) agree urine pregnancy test perform Visit 1 ( must negative ) exit visit ; must lactate ; must agree use medically acceptable form birth control1 throughout study duration . Women childbearing potential include female experience menarche experience menopause ( define amenorrhea great 12 consecutive month ) undergo successful surgical sterilization ( hysterectomy , bilateral tubal ligation , bilateral oophorectomy ) . Have know sensitivity allergy class medication active ingredient study medication study medication 's component ; Have intraocular inflammation ( e.g. , white blood cell flare ) present study eye Visit 1slit lamp examination ; Have score great `` 0 '' Ocular Pain Assessment Visit 1 2 study eye ; Have immunosuppressive autoimmune disease opinion Investigator could affect intraocular inflammation normal heal process eye ; Have active chronic/recurrent ocular systemic disease uncontrolled likely affect wound heal ; Currently suspect know malignancy currently receive antineoplastic therapy ; Be female currently pregnant , planning pregnancy , lactating , use medically acceptable form birth control throughout study duration , positive urine pregnancy test Visit 1 ; Use antiinflammatory agent , analgesics/pain reliever ( include opioids , narcotic pain medication ) immunomodulating agent , systemically , either eye , and/or use medication benign prostatic hyperplasia ( BPH ) , washout period duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>